of purulent material suggested Gram-positive pyogenic infection. In addition, appropriate pretreatment cultures were inoculated directly onto blood agar, phenol ethanol, and MacConkey's media. Venous blood cultures were obtained on all patients with fever in excess of 100°F. Pneumococci were identified by the inhibitory effect of a filter paper disc impregnated with five micrograms of ethyl hydrocuprein hydrochloride.' Beta hemolytic streptococci were grouped on the basis of inhibition by a disc impregnated with 0.02 units of bacitracin.8 Coagulase-positive staphylococci were considered to be Staphylococcus aureus.
Cephaloridine was supplied in ampules containing one gram of white powder,* which was dissolved in 2 to 4 milliliters of sterile normal saline prior to use. All patients were treated with cephaloridine by the intramuscular route since absorption after oral administration is poor.' Dose and duration of therapy was determined by the type of infection, antibiotic sensitivity pattern of the infecting agent and the patient's clinical response. The most frequent dosage schedule consisted of 250 milligrams, 12 hourly for 10 days, but ranged from 0.5 grams to 4 grams per day for 5 to 42 days. The drug was used preferentially in patients with a history of penicillin hypersensitivity. Patients were excluded from the study if they received concomitant therapy with other antibiotics. Toxic effects of the drug were assessed by white blood cell count, differential cell count, hematocrit, total and direct bilirubin, serum glutamic oxaloacetic acid transaminase, thymol turbidity, cephalin flocculation, blood urea nitrogen, and urinalysis values obtained prior to, during, and after therapy. Erythrocyte glucose-6-phosphate dehydrogenase activity was determined on some patients by the brilliant cresyl-blue dye test. '17 Laboratory studies
One hundred thirty-eight strains of Gram-positive bacteria isolated from patients with clinical infections hospitalized at the West Haven Veterans Administration Hospital were studied. These included 38 strains of Staphylococcus aureus, 28 strains of Staphylococcus albus, 18 strains of Diplococcus pneumoniae, 17 strains of Beta hemolytic streptococci, 21 strains of Streptococcus viridaAns, and 16 strains of Streptococcus faecalis (enterococci). Organisms were collected from the Clinical Bacteriology Laboratory, subcultured, and re-identified according to the scheme of Schaub, Foley, Scott, and Bailey8 in our Research Bacteriology Laboratory before antibiotic sensitivity tests were performed.
All organisms were tested with cephaloridine by both tube-dilution and single antibiotic disc methods. In addition, organisms were tested with four other antibiotics by the single disc method. Discs (Difco) contained the following concentrations of antibiotics: cephalothin, 30 micrograms; penicillin G, 2 and 10 units; methicillin, 5 micrograms; and nafcillin, 1 microgram. A modification of the single-disc method of Kirby, Yoshihara, Sundstedt, and Warren9 and Turck, Lindemeyer, and Petersdorf'0 was used in the present study. The total diameter of the zone of inhibition, including the diameter of the disc (6 millimeters) was measured after overnight incubation of the plates at 370 C. Tube dilution sensitivities were performed as follows: 1 to 2 colonies of a pure culture of each isolate were transferred from stock media into 10 milliliters of tryptocase soy broth and incubated for 6 to 8 hours at 370 C. On occasion, slowly growing organisms were incubated overnight. The 
RESULTS

Clinical studies
Of the twenty-four patients treated with cephaloridine, eighteen had clinical evidence of bacterial pneumonia. Sixteen of these patients had an underlying illness complicating their pneumonia: alcoholism in 6, chronic pulmonary disease in 3, congestive heart failure in 4, diabetes mellitus and lymphoma in 1 each and 1 patient had cancer and chronic pulmonary disease. All patients were seriously ill. Pneumococci were seen on gram stain of sputum in 17 and were isolated from sputum cultures in 12 and from blood cultures in 3 patients. One patient had staphylococcal pneumonia. Sixteen patients had roentgenographic evidence of pulmonary infiltration.
The first nine of these 18 patients with pneumonia received 250 milligrams of cephaloridine every 12 hours and were treated for 5 to 12 days, receiving from 2.25 to 5.75 grams during therapy. Eight of these nine patients responded satisfactorily and were cured of the infection. One patient with Hodgkin's disease was admitted to hospital with a month history of cough, fever, pleuritic chest pain and purulent sputum. Pneumococci were cultured from sputum prior to therapy but could not be recovered from sputum cultured after two days of cephaloridine treatment. Nevertheless, fever and pulmonary infiltration remained unchanged despite eight days of antibiotic therapy. Subsequent nitrogen mustard therapy produced a dramatic lysis of fever. The pulmonary infiltrate remained unchanged radiographically for several months at which time the patient died of Hodgkin's disease. A chronic pneumonia was demonstrated at post mortem examination. Although the clinical response to this dose of cephaloridine appeared satisfactory in the eight patients who recovered, they became afebrile slowly (mean duration of fever 3.6 days).
The next nine patients with bacterial pneumonia were subsequently treated with one gram of cephaloridine administered initially, followed by 250 milligrams at 12-hour intervals for 6 to 10 days, receiving from 3.25 to 5.25 grams of cephaloridine during this period. Eight patients in this group responded satisfactorily to treatment with more rapid lysis of fever (mean duration of fever 1.7 days) as compared with patients receiving an initial dose of 250 milligrams of cephaloridine. One patient with cancer and chronic pulmonary disease died on the sixth day of cephaloridine therapy.
Of the remaining six patients treated with cephaloridine five had soft tissue infections and one had a brain abscess. Organisms were recovered from these patients by aspiration of advancing margins of cellulitis or small open lesions of the infected area. Four patients were treated for cellulitis due to mixed infections caused by Staphylococcus aureus and Group A beta hemnolytic Streptococci. Staphylococcus aureus and Escherichia coli were cultured from a brain abscess which was the most severe infection treated in this group. This patient was febrile, comatose and hemiparetic at the initiation of therapy. Cephaloridine, 1 gram every 6 hours, was administered for two weeks combined with early incision and drainage, followed by 0.5 gram of cephaloridine every 6 hours for an additional four weeks, which resulted in prompt improvement and complete recovery. One patient with long-standing agranulocytosis of uncertain etiology responded clinically to cephaloridine and surgical drainage of a palmar abscess from which Staphylococcus albus and Aerobacter species were cultured although the gramnegative rod was not sensitive in vitro to cephaloridine.
Laboratory abnormalities potentially attributable to cephaloridine therapy were observed in five patients. Two of six Negro patients developed anemias during treatment and both patients were found to have glucose-6-phosphate dehydrogenase deficient erythrocytes.* Hematocrit determinations returned to normal values following therapy.
A past history of penicillin hypersensitivity was obtained from 7 of the 24 patients studied and one developed asymptomatic eosinophilia during therapy. No allergic manifestations were observed in other patients studied.
Two patients developed transient elevations of the serum glutamicoxaloacetic-transaminase during therapy. One patient had received whole *Erythrocyte glucose-6-phosphate dehydrogenase determinations were kindly performed by Dr Eighteen of the 24 patients had normal renal function prior to, during, and after cephaloridine treatment. Six patients had elevated blood urea Table 1 and Figure 1 . This antibiotic inhibited 100 per cent of S. aureus, 100 per cent of penicillin-sensitive S. albus, 85 per cent of penicillin-resistant S. albus, 100 per cent of D. pneumoniae, 95 per cent of S. viridans, 76 per cent of S. pyogenes, and only 37 per cent of S. faecalis. Cephaloridine was also found to be bactericidal for the majority of susceptible strains and there was, in general, a close correlation between inhibition (MIC) and killing (MBC) of most Gram-positive bacteria. The cumulative per cent of these strains susceptible to increasing concentrations of cephaloridine is shown in Figure 1 .
Comparison of single disc and tube dilution sensitivities. The zone diameter of inhibition of Gram-positive bacteria tested with 30 micrograms of cephaloridine is illustrated in Figure 2 . A zone size of 6 millimeters indicates no inhibition since the antibiotic disc has a diameter of 6 millimeters and this diameter is included in the final reading. The zone of inhibtion for each strain studied is plotted against the minimum concentration (MIC) of cephaloridine necessary to inhibit the growth of that strain as determined by tube-dilution sensitivities. Figure 2 illustrates the close correlation between disc and tube-dilution sensitivities of cephaloridine against S. aureus, S. albus, D. pneunzoniae, S. ziridans, and Beta hemolytic streptococci. Most discrepancies between disc and tube-dilution sensitivities were observed with strains of S. faecalis. With the exception of enterococci, Gram-positive bacteria with zones of inhibition greater than 14 millimeters had minimunm inhibitory concentrations well within the expected serum level of cephaloridine following a single intramuscular injection of 250 or 500 milligrams. Comnparison by disc sensitivity of cephaloridine wtih other antibiotics. Figure 3 illustrates the comparative disc sensitivity of 138 strains of Grampositive bacteria when tested against cephaloridine, cephalothin, penicillin G, methicillin, and nafcillin. The per cent of strains inhibited by a 30-microgram cephaloridine disc compared favorably with those inhibited by a 30 microgram cephalothin disc. Although 12 strains of S. faecalis were sensitive to cephaloridine by the disc method, only six of these were also sensitive by the tube-dilution method. One strain of a Group A beta 16 hemolytic streptococcus was also sensitive to cephaloridine by the disc method but resistant by tube-dilution sensitivity. nate refer to number of strains tested; on abscissa,
DISCUSSION
The results of this study suggest that cephaloridine is an effective antimicrobial agent in the therapy of pulmonary and soft tissue infections due to pneumococci, group A beta hemolytic streptococci and staphylococci. Twenty-two patients treated with cephaloridine were cured of their infec-tion. One patient, although bacteriologically "cured," was considered a treatment failure when fever and pulmonary infiltration persisted. However, these latter findings were probably due to Hodgkin's disease since fever promptly disappeared with nitrogen mustard therapy. Athough small doses of cephaloridine (250 milligrams every 12 hours) were effective in the treatment of pneumococcal pneumonia, in this study an initial dose of one gram followed by 250 milligrams every 12 hours resulted in more rapid clinical improvement.
These excellent therapeutic results are in contrast with previous studies2" in which cephaloridine was used to treat predominately Gram-negative infections. Murdoch and colleagues4 observed treatment failures in 46 per cent of 43 patients studied and Stewart and Holt2 reported that 25 per cent of patients failed to respond to cephaloridine therapy. Urinary tract abnormalities and the presence of foreign bodies were thought to be responsible for the poor results observed. However, the minimal inhibitory concentration of cephaloridine for most susceptible Gram-negative bacteria is one hundred to one thousand times greater than for Gram-positive cocci.' Stewart' also noted less striking cellular morphologic abnormalities in Gram-negative rods exposed to cephaloridine than at equivalent concentrations of ampicillin or penicillin G. These observations may also account for the less impressive results observed in the treatment of Gram-negative infections.
Toxicity of new therapeutic agents is difficult to assess during preliminary clinical studies since patients are often quite ill with multiple system disease and receive many pharmacologically active agents. Adverse reactions should not be considered "documented" in the absence of confirmatory laboratory tests or rechallenge with the suspected agent. ' Five patients treated with cephaloridine developed probable adverse reactions that might be attributed to the drug. None of these reactions was severe or life-threatening. The elevated serum glutamic-oxalacetictransaminase values noted in two patients were minimal and were the only abnormalities of liver function observed. A previous blood transfusion in one patient complicates interpretation since elevated transaminase values may be the only indication of serum hepatitis.'l Slight elevations of serum transaminase values have been occasionally observed in patients treated with other antibiotics. ' The significance of these observations has not been clearly defined. Eosinophilia was the only allergic reaction observed and occurred in one patient with a past history of penicillin hypersensitivity.
The anemia that developed in two patients with glucose-6-phosphate dehydrogenase-deficient erythrocytes appeared to be drug related although 18 Volume 39, August, 1966 Cephlalaridine THORNTON, ANDRIOLE pneumococcal infection may have been responsible, at least in part, for the fall in hematocrit values. Anemia has not been reported in other patients treated with cephaloridine."' It is unlikely that patients with this enzyme deficiency were studied previously although reports from Great Britain do not identify the racial background of cephaloridine-treated patients.2' Further clinical investigation is necessary to define more clearly this apparent association and other potential adverse reactions to cephaloridine.
Progressive nitrogen retention, which has recently been observed in some patients with initially normal or reduced renal function when large daily doses of cephaloridine have been administered,'5 did not occur with small daily doses of cephaloridine even though some patients had reduced renal function before therapy.
Cephaloridine and cephalothin are both clinically effective in the treatment of infections due to the pneumococcus, group A beta hemolytic streptococcus and penicillinase and nonpenicillinase-producing staphylococcus and can probably be used with relative safety in penicillin-sensitive individuals.3 However, an anaphylactoid reaction to cephalothin has been described in a penicillin-sensitive patient. 16 When compared with cephalothin, cephaloridine has the distinct advantages of greater potency against bacterial infections caused by Grampositive cocci, less frequent injections, less and frequently absent pain at the injection site, greater solubility, absence of protein binding, and prolonged antibacterial serum levels.2" Finally, the results of the laboratory data observed in the present study indicate that, with the exception of some strains of enterococci, the single high-concentration disc method correlates closely with the tube-dilution method and is reliable in determining the antimicrobial sensitivity or resistance of strains of staphylococci, pneumococci, and streptococci to cephaloridine.
SUMMARY
The new semisynthetic antibiotic, cephaloridine, was effective in the treatment of twenty-two of twenty-four pulmonary and soft tissue bacterial infections due to staphylococci, pneumococci, and streptococci. Although sixteen of eighteen patients with pneumonia responded well to therapy, those treated with a higher initial dose of cephaloridine seemed to improve and become afebrile more rapidly. Anemia developed during therapy in two patients with glucose-6-phosphate dehydrogenase-deficient erythrocytes and was the most significant adverse effect observed. Progressive nitrogen retention was not observed during or after therapy in six patients with elevated blood urea nitrogen values prior to cephaloridine treatment.
In sitro sensitivity studies of 138 Gram-positive organisms indicated that, with the exception of enterococci, the single high-concentration disc method compared favorably with the tube-dilution method and was reliable in determining the antimicrobial sensitivity of strains of staphylococci, pneumococci, and streptococci to cephaloridine.
